Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors

Hepatogastroenterology. 2003 Sep-Oct;50(53):1431-5.

Abstract

Background/aims: Usefulness of immunohistochemistry and c-kit proto-oncogene mutation was examined for determining malignancy in 24 cases of gastrointestinal stromal tumors.

Methodology: Cases were histologically diagnosed and subjected to immunohistochemical staining and c-kit gene analysis. All parameters were compared to prognosis.

Results: There were significant differences in tumor size, central necrosis, mitotic activity and histological diagnosis between recurrent and non-recurrent cases. Positivity to KIT staining was 100% in recurrent and 87.5% in non-recurrent cases. Positivity to Ki-67 and p53 staining were significantly higher in recurrent cases than in non-recurrent cases. Mutations in exon 11 of the c-kit gene were significantly more frequent in recurrent cases than in non-recurrent cases.

Conclusions: Histological diagnosis, tumor size, central necrosis, and mitotic activity were reconfirmed to be indicators for recurrence of gastrointestinal stromal tumors. Furthermore, it is suggested that positivity of Ki-67 and p53 immunostaining and c-kit gene mutation also need to be done for prediction of recurrence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Gastrointestinal Neoplasms / genetics*
  • Gastrointestinal Neoplasms / metabolism
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm Recurrence, Local / genetics
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-kit / metabolism*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Ki-67 Antigen
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Tumor Suppressor Protein p53
  • Proto-Oncogene Proteins c-kit